Therapy News and Research

RSS

NHLBI to hold Symposium to review latest findings in Cardiovascular Regenerative Medicine

With advancements in the field of stem cell research accelerating, the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) will hold its third Symposium on Cardiovascular Regenerative Medicine to review the latest findings in the field and examine future directions.

9 Oct 2009

American Shared Hospital Services updates on Todd Cancer Institute's proton therapy center development

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today shared a recent announcement regarding progress in the development of a proton therapy center at Todd Cancer Institute at Long Beach Memorial Medical Center.

8 Oct 2009

Lpath reports positive Phase 1 clinical trial results of iSONEP in wet-AMD patients

Lpath, Inc., the category leader in lipidomics-based therapeutics, reported positive summary results of its single-dose Phase 1 clinical trial of iSONEP™ in wet-AMD patients.

8 Oct 2009

Epitope spreading can get triggered by live, attenuated Listeria vaccine

Advaxis, Inc. (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, in collaboration with its scientific founder and Scientific Advisory Board Chair Dr. Yvonne Paterson, have shown that epitope spreading occurs in response to a form of the Company’s proprietary technology that targets tumor blood vessels (anti angiogenic antigen).

8 Oct 2009

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

BioDelivery Sciences International, Inc. announced that its commercial partner Meda will launch the FDA-approved ONSOLIS (fentanyl buccal soluble film) next week for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

8 Oct 2009

eClinicalWorks signs agreement with Healthwise to provide two Healthwise solutions to help its physicians

eClinicalWorks and Healthwise announced today an agreement to provide two Healthwise solutions to eClinicalWorks physician clients. Healthwise Information Therapy (Ix) Patient Instructions, take-home patient educational materials, integrates within the eClinicalWorks EMR; and the Healthwise Knowledgebase, an online health information library, has patient-specific connections within the eClinicalWorks secure Patient Portal.

8 Oct 2009

Development of lab-on-chip system for breast cancer detection and therapy

IMEC, a leading European research center in nanotechnology, the Institüt für Mikrotechnik Mainz (IMM), one of the leading European research centers in microfluidics, and their partners within the European Sixth Framework Project MASCOT achieve a major milestone in the development of a lab-on-chip for the detection and therapy evaluation of breast cancer.

8 Oct 2009

CombinatoRx' Prednisolone/Dipyridamole Combination abstract to be presented at the ACR 2009

CombinatoRx, Incorporated today announced that its abstract entitled, “CRx-102 (Prednisolone/Dipyridamole Combination) Enhances Glucocorticoid (GC) Efficacy and Reduces Adverse Effects in OA Therapy: 3-12 Month Results”, has been accepted for oral presentation at the American College of Rheumatology (ACR) 2009 Annual Meeting in Philadelphia on October 20, 2009.

8 Oct 2009

MUSC enrolls first patient in the Stroke Treatment And Revascularization Therapy trial

The Stroke Team at the Medical University of South Carolina (MUSC) in Charleston, SC, including Aquilla Turk, DO, Associate Professor of Radiology, M. Imran Chaudry, MD, Assistant Professor of Radiology, and Raymond D. Turner IV, MD, Assistant Professor of Neurosurgery and Radiology, enrolled the first patient in the Stroke Treatment And Revascularization Therapy (START) trial.

8 Oct 2009

New cancer drugs boost drug spending

Cancer treatments are on track to become the biggest driver of specialty pharmacy spending as its contribution to overall drug spending hit five percent for the first time in the first half of 2009, according to Medco Health Solutions, Inc.

8 Oct 2009

Elderly cancer patients need custom-made treatment to combat the disease

Elderly cancer patients need a combination of treatments tailor-made to their specific needs to successfully combat the disease. The challenge is to boost their immune response to cancer vaccines, because like the rest of our organs, our immune system ages and gradually becomes less efficient as we get older.

8 Oct 2009

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix® (clopidogrel bisulfate) is now being performed by Quest Diagnostics for Scripps Health patients electing to undergo coronary stent procedures.

From Quest Diagnostics 8 Oct 2009

AMAG Pharmaceuticals to present three abstracts at ASN Renal Week meeting

AMAG Pharmaceuticals, Inc. today announced that three abstracts have been accepted for presentation at the American Society of Nephrology (ASN) Renal Week meeting being held October 27-November 1, 2009 in San Diego, CA.

8 Oct 2009

Researchers reveal that H2 Blocker drugs pose no significant risks for the fetus

H2 Blocker drugs, such as Famotidine, Cimetidine and Ranitidine, approved in the U.S. for acid reflux (heartburn), pose no significant risks for the fetus according to a large collaborative cohort study by researchers at Ben-Gurion University of the Negev.

8 Oct 2009

Study discusses possible genetic effects of radiation and cancer drug exposures on future generations

Researchers at the University of Oklahoma Health Sciences Center are helping to lead a massive international study on the possible genetic effects of radiation and cancer drug exposures on future generations.

8 Oct 2009

Antidotes effective for treating acute liver failure patients in early stages of disease

The antidote for acute liver failure caused by acetaminophen poisoning also can treat acute liver failure due to most other causes if given before severe injury occurs, UT Southwestern Medical Center researchers and their colleagues at 21 other institutions have found.

8 Oct 2009

Triple therapy may benefit patients with chronic obstructive pulmonary disease

Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting β-agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany.

8 Oct 2009

Cancer Genome Atlas funds study for analysis and interpretation of tumor genetic data

The Cancer Genome Atlas (TCGA) will fund an effort by scientists at The University of Texas M. D. Anderson Cancer Center to siphon buckets of meaningful information from an ocean of data about the aberrant genetics that drive human cancers.

8 Oct 2009

Hutchinson Center scientists awarded $16.7M to develop progenitor and stem cell tools

The National Heart, Lung and Blood Institute has awarded a total of $16.7 million to Irwin Bernstein, M.D., and Beverly Torok-Storb, Ph.D., both members of the Clinical Research Division at Fred Hutchinson Cancer Research Center. The Hutchinson Center grants represent part of a $170 million effort involving 18 teams of research scientists dedicated to developing stem- and progenitor-cell tools and therapies.

8 Oct 2009

Study suggest childhood cancer survivors are less likely to get married

Childhood cancer survivors typically suffer from the long-term effects of cancer treatment on physical health, and results of a new study suggest that social implications also exist, which may affect their chance of an "I do" at the altar.

8 Oct 2009

Therapy News and Research

NHLBI to hold Symposium to review latest findings in Cardiovascular Regenerative Medicine

American Shared Hospital Services updates on Todd Cancer Institute's proton therapy center development

Lpath reports positive Phase 1 clinical trial results of iSONEP in wet-AMD patients

Epitope spreading can get triggered by live, attenuated Listeria vaccine

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

eClinicalWorks signs agreement with Healthwise to provide two Healthwise solutions to help its physicians

Development of lab-on-chip system for breast cancer detection and therapy

CombinatoRx' Prednisolone/Dipyridamole Combination abstract to be presented at the ACR 2009

MUSC enrolls first patient in the Stroke Treatment And Revascularization Therapy trial

New cancer drugs boost drug spending

Elderly cancer patients need custom-made treatment to combat the disease

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

AMAG Pharmaceuticals to present three abstracts at ASN Renal Week meeting

Researchers reveal that H2 Blocker drugs pose no significant risks for the fetus

Study discusses possible genetic effects of radiation and cancer drug exposures on future generations

Antidotes effective for treating acute liver failure patients in early stages of disease

Triple therapy may benefit patients with chronic obstructive pulmonary disease

Cancer Genome Atlas funds study for analysis and interpretation of tumor genetic data

Hutchinson Center scientists awarded $16.7M to develop progenitor and stem cell tools

Study suggest childhood cancer survivors are less likely to get married

Industry Focus eBook - Cell biology (5th edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News